Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1987-10-21
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0028-2766
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
46
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
324
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:3627328-HLA-D Antigens,
pubmed-meshheading:3627328-HLA-DR Antigens,
pubmed-meshheading:3627328-HLA-DR Serological Subtypes,
pubmed-meshheading:3627328-Humans,
pubmed-meshheading:3627328-Kidney Failure, Chronic,
pubmed-meshheading:3627328-Neoplasms,
pubmed-meshheading:3627328-Phenotype,
pubmed-meshheading:3627328-Renal Dialysis
|
pubmed:year |
1987
|
pubmed:articleTitle |
Malignancy and HLA-DRw13 in patients on maintenance hemodialysis.
|
pubmed:publicationType |
Letter
|